The University of Southampton
University of Southampton Institutional Repository

A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers

A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers
A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers

Objective: Pathological gambling is associated with elevated proportions of nicotine dependence, and tobacco smoking in pathological gamblers has been associated with increased problem-gambling severity. This study examined the addition of N-acetylcysteine to imaginal desensitization in adults with co-occurring nicotine dependence and pathological gambling. Method: Twenty-eight individuals with cooccurring DSM-IV nicotine dependence and pathological gambling who were receiving behavioral therapy were recruited from December 2009 to February 2012 and randomized to augmentation with N-acetylcysteine or placebo in an 12-week, double-blind trial. Subjects were assessed with measures of nicotine and gambling severity and followed for 3 months after treatment. The primary outcomes were the Fagerström Test for Nicotine Dependence and the pathological gambling adaptation of the Yale- Brown Obsessive-Compulsive Scale. Results: During the first 6 weeks, there was a significant benefit of N-acetylcysteine treatment versus placebo on Fagerström Test for Nicotine Dependence total scores (t = -2.224; P = .031). After the initial 6 weeks, all subjects significantly (P < .001) benefited from imaginal desensitization. During the 3-month follow-up, there was a significant additional benefit for N-acetylcysteine versus placebo on measures of problem-gambling severity (t = 2.069; P = .043). Conclusions: N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed.

0160-6689
39-45
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Odlaug, Brian L.
f021d299-d250-44a2-bb17-6f7e16bfa0f6
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Potenza, Marc N.
4331dcd8-d078-437b-a202-85b02faf9d56
Schreiber, Liana R.N.
5d659814-23de-4dec-b9d4-5341ad99738b
Donahue, Christopher B.
99aedc69-21f4-4705-988a-a54cdebfa82a
Kim, Suck Won
9fe9fcb5-3b23-4c3d-9bb9-4e1ef88965f2
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Odlaug, Brian L.
f021d299-d250-44a2-bb17-6f7e16bfa0f6
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Potenza, Marc N.
4331dcd8-d078-437b-a202-85b02faf9d56
Schreiber, Liana R.N.
5d659814-23de-4dec-b9d4-5341ad99738b
Donahue, Christopher B.
99aedc69-21f4-4705-988a-a54cdebfa82a
Kim, Suck Won
9fe9fcb5-3b23-4c3d-9bb9-4e1ef88965f2

Grant, Jon E., Odlaug, Brian L., Chamberlain, Samuel R., Potenza, Marc N., Schreiber, Liana R.N., Donahue, Christopher B. and Kim, Suck Won (2014) A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. Journal of Clinical Psychiatry, 75 (1), 39-45. (doi:10.4088/JCP.13m08411).

Record type: Article

Abstract

Objective: Pathological gambling is associated with elevated proportions of nicotine dependence, and tobacco smoking in pathological gamblers has been associated with increased problem-gambling severity. This study examined the addition of N-acetylcysteine to imaginal desensitization in adults with co-occurring nicotine dependence and pathological gambling. Method: Twenty-eight individuals with cooccurring DSM-IV nicotine dependence and pathological gambling who were receiving behavioral therapy were recruited from December 2009 to February 2012 and randomized to augmentation with N-acetylcysteine or placebo in an 12-week, double-blind trial. Subjects were assessed with measures of nicotine and gambling severity and followed for 3 months after treatment. The primary outcomes were the Fagerström Test for Nicotine Dependence and the pathological gambling adaptation of the Yale- Brown Obsessive-Compulsive Scale. Results: During the first 6 weeks, there was a significant benefit of N-acetylcysteine treatment versus placebo on Fagerström Test for Nicotine Dependence total scores (t = -2.224; P = .031). After the initial 6 weeks, all subjects significantly (P < .001) benefited from imaginal desensitization. During the 3-month follow-up, there was a significant additional benefit for N-acetylcysteine versus placebo on measures of problem-gambling severity (t = 2.069; P = .043). Conclusions: N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed.

This record has no associated files available for download.

More information

Published date: January 2014

Identifiers

Local EPrints ID: 493102
URI: http://eprints.soton.ac.uk/id/eprint/493102
ISSN: 0160-6689
PURE UUID: 17b11245-a89d-44d6-8485-4cd20749f416
ORCID for Samuel R. Chamberlain: ORCID iD orcid.org/0000-0001-7014-8121

Catalogue record

Date deposited: 22 Aug 2024 17:21
Last modified: 23 Aug 2024 01:59

Export record

Altmetrics

Contributors

Author: Jon E. Grant
Author: Brian L. Odlaug
Author: Samuel R. Chamberlain ORCID iD
Author: Marc N. Potenza
Author: Liana R.N. Schreiber
Author: Christopher B. Donahue
Author: Suck Won Kim

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×